vs

Side-by-side financial comparison of BayFirst Financial Corp. (BAFN) and C4 Therapeutics, Inc. (CCCC). Click either name above to swap in a different company.

BayFirst Financial Corp. is the larger business by last-quarter revenue ($11.2M vs $11.0M, roughly 1.0× C4 Therapeutics, Inc.). BayFirst Financial Corp. runs the higher net margin — -22.1% vs -186.0%, a 163.9% gap on every dollar of revenue. On growth, C4 Therapeutics, Inc. posted the faster year-over-year revenue change (112.8% vs 4.7%). Over the past eight quarters, C4 Therapeutics, Inc.'s revenue compounded faster (90.4% CAGR vs -30.4%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted protein degradation therapies for cancer and other severe diseases with high unmet medical needs. It leverages its proprietary TORPEDO platform to design small molecule degraders that eliminate disease-causing proteins, with a pipeline of oncology candidates in preclinical and clinical development, plus strategic partnerships with leading global pharmaceutical firms.

BAFN vs CCCC — Head-to-Head

Bigger by revenue
BAFN
BAFN
1.0× larger
BAFN
$11.2M
$11.0M
CCCC
Growing faster (revenue YoY)
CCCC
CCCC
+108.0% gap
CCCC
112.8%
4.7%
BAFN
Higher net margin
BAFN
BAFN
163.9% more per $
BAFN
-22.1%
-186.0%
CCCC
Faster 2-yr revenue CAGR
CCCC
CCCC
Annualised
CCCC
90.4%
-30.4%
BAFN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BAFN
BAFN
CCCC
CCCC
Revenue
$11.2M
$11.0M
Net Profit
$-2.5M
$-20.5M
Gross Margin
Operating Margin
-25.3%
-210.1%
Net Margin
-22.1%
-186.0%
Revenue YoY
4.7%
112.8%
Net Profit YoY
-125.2%
40.7%
EPS (diluted)
$-0.71
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAFN
BAFN
CCCC
CCCC
Q4 25
$11.2M
$11.0M
Q3 25
$10.2M
$11.2M
Q2 25
$23.1M
$6.5M
Q1 25
$19.8M
$7.2M
Q4 24
$32.9M
$5.2M
Q3 24
$21.7M
$15.4M
Q2 24
$20.8M
$12.0M
Q1 24
$23.0M
$3.0M
Net Profit
BAFN
BAFN
CCCC
CCCC
Q4 25
$-2.5M
$-20.5M
Q3 25
$-18.9M
$-32.2M
Q2 25
$-1.2M
$-26.0M
Q1 25
$-335.0K
$-26.3M
Q4 24
$9.8M
$-34.6M
Q3 24
$1.1M
$-24.7M
Q2 24
$866.0K
$-17.7M
Q1 24
$824.0K
$-28.4M
Operating Margin
BAFN
BAFN
CCCC
CCCC
Q4 25
-25.3%
-210.1%
Q3 25
-253.0%
-306.4%
Q2 25
-7.1%
-441.0%
Q1 25
-2.3%
-402.9%
Q4 24
-728.4%
Q3 24
7.1%
-183.9%
Q2 24
5.9%
-178.6%
Q1 24
5.1%
-1060.2%
Net Margin
BAFN
BAFN
CCCC
CCCC
Q4 25
-22.1%
-186.0%
Q3 25
-184.7%
-286.4%
Q2 25
-5.3%
-402.6%
Q1 25
-1.7%
-363.7%
Q4 24
91.8%
-667.8%
Q3 24
5.2%
-160.6%
Q2 24
4.2%
-147.6%
Q1 24
3.6%
-933.2%
EPS (diluted)
BAFN
BAFN
CCCC
CCCC
Q4 25
$-0.71
$-0.09
Q3 25
$-4.66
$-0.44
Q2 25
$-0.39
$-0.37
Q1 25
$-0.17
$-0.37
Q4 24
$2.21
$-0.50
Q3 24
$0.18
$-0.35
Q2 24
$0.12
$-0.26
Q1 24
$0.11
$-0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAFN
BAFN
CCCC
CCCC
Cash + ST InvestmentsLiquidity on hand
$207.0M
$74.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$87.6M
$256.6M
Total Assets
$1.3B
$359.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAFN
BAFN
CCCC
CCCC
Q4 25
$207.0M
$74.6M
Q3 25
$118.5M
$58.8M
Q2 25
$77.3M
$78.2M
Q1 25
$63.2M
$51.3M
Q4 24
$77.8M
$55.5M
Q3 24
$64.4M
$59.6M
Q2 24
$60.8M
$73.1M
Q1 24
$57.5M
$89.7M
Stockholders' Equity
BAFN
BAFN
CCCC
CCCC
Q4 25
$87.6M
$256.6M
Q3 25
$89.7M
$154.4M
Q2 25
$108.2M
$174.1M
Q1 25
$110.1M
$195.1M
Q4 24
$110.9M
$216.0M
Q3 24
$102.3M
$242.7M
Q2 24
$101.0M
$247.1M
Q1 24
$100.6M
$258.3M
Total Assets
BAFN
BAFN
CCCC
CCCC
Q4 25
$1.3B
$359.1M
Q3 25
$1.3B
$265.5M
Q2 25
$1.3B
$296.5M
Q1 25
$1.3B
$319.5M
Q4 24
$1.3B
$349.6M
Q3 24
$1.2B
$376.1M
Q2 24
$1.2B
$381.1M
Q1 24
$1.1B
$398.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAFN
BAFN
CCCC
CCCC
Operating Cash FlowLast quarter
$285.3M
$-22.1M
Free Cash FlowOCF − Capex
$285.0M
FCF MarginFCF / Revenue
2554.2%
Capex IntensityCapex / Revenue
2.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$469.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAFN
BAFN
CCCC
CCCC
Q4 25
$285.3M
$-22.1M
Q3 25
$47.3M
$-31.2M
Q2 25
$63.3M
$-12.1M
Q1 25
$74.2M
$-33.3M
Q4 24
$390.5M
$-17.9M
Q3 24
$90.8M
$-24.1M
Q2 24
$78.8M
$-5.0M
Q1 24
$123.5M
$-18.1M
Free Cash Flow
BAFN
BAFN
CCCC
CCCC
Q4 25
$285.0M
Q3 25
$47.3M
$-31.6M
Q2 25
$63.1M
Q1 25
$74.1M
Q4 24
$388.8M
$-17.9M
Q3 24
$90.5M
$-24.1M
Q2 24
$78.4M
$-5.2M
Q1 24
$122.5M
FCF Margin
BAFN
BAFN
CCCC
CCCC
Q4 25
2554.2%
Q3 25
462.2%
-281.5%
Q2 25
272.7%
Q1 25
375.1%
Q4 24
1180.9%
-346.5%
Q3 24
416.5%
-157.2%
Q2 24
376.1%
-43.1%
Q1 24
532.5%
Capex Intensity
BAFN
BAFN
CCCC
CCCC
Q4 25
2.7%
Q3 25
0.1%
3.7%
Q2 25
0.8%
Q1 25
0.4%
Q4 24
5.1%
0.1%
Q3 24
1.5%
0.1%
Q2 24
1.9%
1.6%
Q1 24
4.4%
0.0%
Cash Conversion
BAFN
BAFN
CCCC
CCCC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
39.95×
Q3 24
79.85×
Q2 24
90.94×
Q1 24
149.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons